Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Relx PLC Director's Dealing 2018

Sep 6, 2018

5248_dirs_2018-09-06_27beae94-9660-4b84-8cd1-bc70182bd42e.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0523A

RELX PLC

06 September 2018

ISSUED ON BEHALF OF RELX PLC AND RELX NV

Director/PDMR Shareholdings

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Gunjan Aggarwal
2 Reason for the notification
a) Position/status PDMR
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name RELX NV
b) LEI 549300XO8R7MPISUO753
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of €0.07 each
Identification code ISIN: NL0006144495
b) Nature of the transaction Sale
c) Price(s) and volume(s)
Price(s) Volume(s)
€18.72 1,224
d) Aggregated information n/a (single transaction)
- Aggregated volume
- Price
e) Date of the transaction 2018-09-06
f) Place of the transaction Euronext Amsterdam Stock Exchange (XAMS)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHLLFFRAIIRIIT